Mapping the paratope of anti-CD4 recombinant fab 13B8.2 by combining parallel peptide synthesis and site-directed mutagenesis

被引:20
作者
Bès, C
Briant-Longuet, L
Cerutti, M
Heitz, F
Troadec, S
Pugnière, M
Roquet, F
Molina, F
Casset, F
Bresson, D
Péraldi-Roux, S
Devauchelle, G
Devaux, C
Granier, C
Chardès, T
机构
[1] CNRS, UMR 5094, Inst Biotechnol & Pharmacol, Fac Pharm, Montpellier 5, France
[2] CNRS, UMR 5121, Lab Infect Retrovirales & Signalisat Cellulaire, Inst Biol, F-34060 Montpellier 2, France
[3] INRA, CNRS, UMR 5087, Lab Pathol Comparee, F-30380 St Christol Les Ales, France
[4] CNRS, UPR 1086, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France
[5] Syntem, F-30035 Nimes 1, France
关键词
D O I
10.1074/jbc.M210694200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analyzed antigen-binding residues from the variable domains of anti-CD4 antibody 13B8.2 using the Spot method of parallel peptide synthesis. Sixteen amino acids, defined as Spot critical residues (SCR), were identified on the basis of a 50% decrease in CD4 binding to alanine analogs of reactive peptides. Recombinant Fab 13B8.2 mutants were constructed with alanine residues in place of each of the 16 SCR, expressed in the baculovirus cell system, and purified. CD measurements indicated that the mutated proteins were conformationally intact, with a beta-sheet secondary structure similar to that of wild-type Fab. Compared with the CD4-binding capacity of wildtype Fab 13B8.2, 11 light (Y32-L, W35-L, Y36-L, H91-L, and Y92-L) and heavy chain (H35-H, R38-H, W52-H, R53-H, F100K-H, and W103-H) Fab single mutants showed a decrease in CD4 recognition as demonstrated by enzymelinked immunosorbent assay, BIAcore, and flow cytometry analyses. The five remaining Fab mutants showed antigen-binding properties similar to those of wild-type Fab. Recombinant Fab mutants that showed decreased CD4 binding also lost their capacity to inhibit human immunodeficiency virus promoter activation and the antigen-presenting ability that wild-type Fab displays. Molecular modeling of the 13B8.2 antibody paratope indicated that most of these critical residues are appropriately positioned inside the putative CD4-binding pocket, whereas the five SCR that were not confirmed by mutagenesis show an unfavorable positioning. Taken together, these results indicate that most of the residues defined by the Spot method as critical matched with important residues defined by mutagenesis in the whole protein context. The identification of critical residues for CD4 binding in the paratope of anti-CD4 recombinant Fab 13B8.2 provides the opportunity for the generation of improved anti-CD4 molecules with more efficient pharmacological properties.
引用
收藏
页码:14265 / 14273
页数:9
相关论文
共 46 条
[1]   A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4(+) T cells in chimpanzees: In vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4 [J].
Anderson, D ;
Chambers, K ;
Hanna, N ;
Leonard, J ;
Reff, M ;
Newman, R ;
Baldoni, J ;
Dunleavy, D ;
Reddy, M ;
Sweet, R ;
Truneh, A .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (01) :73-84
[2]   AN ANTIBODY THAT BINDS THE IMMUNOGLOBULIN CDR3-LIKE REGION OF THE CD4 MOLECULE INHIBITS PROVIRUS TRANSCRIPTION IN HIV-INFECTED T-CELLS [J].
BENKIRANE, M ;
CORBEAU, P ;
HOUSSET, V ;
DEVAUX, C .
EMBO JOURNAL, 1993, 12 (13) :4909-4921
[3]   Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1 [J].
Bès, C ;
Briant-Longuet, L ;
Cerruti, M ;
DeBerardinis, P ;
Devauchelle, G ;
Devaux, C ;
Granier, C ;
Chardès, T .
FEBS LETTERS, 2001, 508 (01) :67-74
[4]  
Bes Cedric, 2001, Human Antibodies, V10, P67
[5]  
Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171
[6]   The protein tyrosine kinase p56lck is required for triggering NF-κB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4 [J].
Briant, L ;
Robert-Hebmann, V ;
Acquaviva, C ;
Pelchen-Matthews, A ;
Marsh, M ;
Devaux, C .
JOURNAL OF VIROLOGY, 1998, 72 (07) :6207-6214
[7]  
Briant L, 2000, Adv Pharmacol, V48, P373
[8]   Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family [J].
Chardes, T ;
Villard, S ;
Ferrières, G ;
Piechaczyk, M ;
Cerutti, M ;
Devauchelle, G ;
Pau, B .
FEBS LETTERS, 1999, 452 (03) :386-394
[9]   Refined structure of the monoclonal antibody HyHEL-5 with its antigen hen egg-white lysozyme [J].
Cohen, GH ;
Sheriff, S ;
Davies, DR .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1996, 52 :315-326
[10]  
CORBEAU P, 1993, J IMMUNOL, V150, P290